+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years +
All Genders
ID05184816

Phase 1a1b Study of Intrathecal Deferoxamine for Treating Leptomeningeal Metastases from Solid Tumors

Led by Memorial Sloan Kettering Cancer Center · Updated on 2026-07-14

32

Participants Needed

7

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating whether intrathecal deferoxamine DFO, administered directly into the cerebrospinal fluid, is a safe treatment for people with leptomeningeal metastasis from solid tumor cancers. This phase 1a1b study aims to find the highest dose of DFO that causes few or mild side effects and to understand how the body absorbs and responds to the drug. The research also explores the preliminary effectiveness of DFO in this patient group. During phase 1a, patients receive escalating doses of intrathecal DFO through an Ommaya reservoir, starting with twice-weekly doses in cycle 1, then reducing frequency in later cycles until disease progression or intolerable side effects. Dose escalation follows an accelerated scheme initially, switching to a traditional 33 design based on toxicity observations. Phase 1b uses the recommended dose from phase 1a with the same dosing schedule, focusing on further safety and early effectiveness assessments. Participants will undergo regular monitoring for side effects, dosing toxicities, and drug levels during the first 28 days of each dosing cohort. Researchers will assess neurological symptoms and response to treatment through imaging and clinical evaluations. The study includes detailed safety tracking, pharmacokinetics, and pharmacodynamics analyses, and participants remain on study until leptomeningeal metastasis progression, intolerable toxicity, or death. The overall study duration extends up to 2027.

CONDITIONS

Brief Title

A Study of Deferoxamine (DFO) in People With Leptomeningeal Metastasis

Research Team

J

Jessica Wilcox, MD

A

Adrienne Boire, MD,PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here